1. Home
  2. INDP vs ASTC Comparison

INDP vs ASTC Comparison

Compare INDP & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • ASTC
  • Stock Information
  • Founded
  • INDP 2000
  • ASTC 1984
  • Country
  • INDP United States
  • ASTC United States
  • Employees
  • INDP N/A
  • ASTC N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • Sector
  • INDP Health Care
  • ASTC Industrials
  • Exchange
  • INDP Nasdaq
  • ASTC Nasdaq
  • Market Cap
  • INDP 10.2M
  • ASTC 11.9M
  • IPO Year
  • INDP N/A
  • ASTC 1995
  • Fundamental
  • Price
  • INDP $0.94
  • ASTC $7.27
  • Analyst Decision
  • INDP Strong Buy
  • ASTC
  • Analyst Count
  • INDP 2
  • ASTC 0
  • Target Price
  • INDP $8.50
  • ASTC N/A
  • AVG Volume (30 Days)
  • INDP 25.7K
  • ASTC 39.8K
  • Earning Date
  • INDP 11-12-2024
  • ASTC 02-10-2025
  • Dividend Yield
  • INDP N/A
  • ASTC N/A
  • EPS Growth
  • INDP N/A
  • ASTC N/A
  • EPS
  • INDP N/A
  • ASTC N/A
  • Revenue
  • INDP N/A
  • ASTC $1,273,000.00
  • Revenue This Year
  • INDP N/A
  • ASTC N/A
  • Revenue Next Year
  • INDP N/A
  • ASTC N/A
  • P/E Ratio
  • INDP N/A
  • ASTC N/A
  • Revenue Growth
  • INDP N/A
  • ASTC 11.96
  • 52 Week Low
  • INDP $0.84
  • ASTC $6.56
  • 52 Week High
  • INDP $3.10
  • ASTC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • ASTC 50.55
  • Support Level
  • INDP $0.94
  • ASTC $7.04
  • Resistance Level
  • INDP $1.01
  • ASTC $8.15
  • Average True Range (ATR)
  • INDP 0.06
  • ASTC 0.47
  • MACD
  • INDP 0.00
  • ASTC 0.05
  • Stochastic Oscillator
  • INDP 28.24
  • ASTC 43.23

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: